Market Closed -
Canadian Securities Exchange
01:22:39 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.215
CAD
|
+4.88%
|
|
0.00%
|
-2.27%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
59.8
|
58.71
|
13.99
|
12.31
|
Enterprise Value (EV)
1 |
61.16
|
61.53
|
16.92
|
14.58
|
P/E ratio
|
-7.19
x
|
-16.3
x
|
-3.46
x
|
-3.14
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
23,926,537
x
|
10,431,301
x
|
1,052,467
x
|
554,098
x
|
EV / Revenue
|
24,469,625
x
|
10,931,319
x
|
1,272,975
x
|
655,990
x
|
EV / EBITDA
|
-8.65
x
|
-47.4
x
|
30.3
x
|
-38
x
|
EV / FCF
|
-20,698,797
x
|
-130,984,634
x
|
6,359,674
x
|
7,142,853
x
|
FCF Yield
|
-0%
|
-0%
|
0%
|
0%
|
Price to Book
|
5.93
x
|
2.62
x
|
0.77
x
|
0.84
x
|
Nbr of stocks (in thousands)
|
43,334
|
65,971
|
55,971
|
55,971
|
Reference price
2 |
1.380
|
0.8900
|
0.2500
|
0.2200
|
Announcement Date
|
4/28/21
|
5/2/22
|
5/1/23
|
4/23/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
2.499
|
5.629
|
13.3
|
22.22
|
EBITDA
1 |
-1.555
|
-7.074
|
-1.299
|
0.5582
|
-0.3836
|
EBIT
1 |
-1.673
|
-7.165
|
-2.392
|
-0.8
|
-1.794
|
Operating Margin
|
-
|
-286.67%
|
-42.49%
|
-6.02%
|
-8.07%
|
Earnings before Tax (EBT)
1 |
-3.987
|
-7.616
|
-2.765
|
-4.338
|
-3.862
|
Net income
1 |
-3.987
|
-7.616
|
-2.75
|
-4.282
|
-3.545
|
Net margin
|
-
|
-304.71%
|
-48.86%
|
-32.2%
|
-15.95%
|
EPS
2 |
-0.1450
|
-0.1919
|
-0.0548
|
-0.0723
|
-0.0700
|
Free Cash Flow
|
-
|
-2.955
|
-0.4697
|
2.661
|
2.041
|
FCF margin
|
-
|
-118.22%
|
-8.35%
|
20.02%
|
9.18%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
476.71%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/12/20
|
4/28/21
|
5/2/22
|
5/1/23
|
4/23/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3.01
|
1.36
|
2.81
|
2.93
|
2.26
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-1.938
x
|
-0.1919
x
|
-2.167
x
|
5.252
x
|
-5.903
x
|
Free Cash Flow
|
-
|
-2.95
|
-0.47
|
2.66
|
2.04
|
ROE (net income / shareholders' equity)
|
-
|
-100%
|
-16.9%
|
-21.1%
|
-21.5%
|
ROA (Net income/ Total Assets)
|
-
|
-35.7%
|
-7.04%
|
-1.65%
|
-3.5%
|
Assets
1 |
-
|
21.33
|
39.09
|
259.3
|
101.4
|
Book Value Per Share
2 |
0.1400
|
0.2300
|
0.3400
|
0.3300
|
0.2600
|
Cash Flow per Share
2 |
0.0700
|
0.0300
|
0.0100
|
0.0200
|
0.0200
|
Capex
1 |
6.55
|
1.8
|
0.58
|
0.63
|
0.68
|
Capex / Sales
|
-
|
72.06%
|
10.32%
|
4.7%
|
3.06%
|
Announcement Date
|
6/12/20
|
4/28/21
|
5/2/22
|
5/1/23
|
4/23/24
|
|
1st Jan change
|
Capi.
|
---|
| -2.27% | 8.79M | | +35.04% | 5.92B | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | -7.89% | 1.68B | | +0.09% | 1.65B | | -12.97% | 1.53B |
Alternative Medicine
|